100340 15/sc/0432 181387 HRA Approval TRANSFORM: A Randomized, Doubleblind, Multicenter, Active-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Subjects with Treatment-resistant Depression No 91 No 16/06/2015 05/10/2016 15/06/2016 12/10/2016 04/01/2017 04/01/2017 F - No patients seen inclusion exclusion criteria is resulting in many pre-screen fails of clinical records. no eligible patients seen Neither 100341 15/sc/0434 181955 HRA Approval SUSTAIN-2 3004: An Open-label, Safety and Efficacy Study of Intranasal Esketamine in Depression No No 18/10/2016 F - No patients seen inclusion exclusion criteria is resulting in many of clinical records. no eligible patients seen Neither 100342 16/nw/0727 187851 HRA Approval Multi Centre RCT of a group psychOlogical intervention for poStnatal depression in britisH mothers of south asiaN origIn - ROSHNI-2 Yes- date unavailable No 05/01/2017 H - Contracting delays NIHR sign off delayed over christmas break due to staff illness. Neither 100343 16/nw/0500 188072 HRA Approval Speech and language -phase 1 survey No No 12/12/2016 J - Other consents were and as such the study has not allocated recruitment to any specific sites and has been deemed exempt from its Sponsor 100344 15/nw/0330 163066 HRA Approval A pilot study to test the feasibility and acceptability of delivering recovery focused cognitive-behavioural therapy to older adults with bipolar disorder Yes 17/02/2017 30 Yes 18/01/2017 100387 15/nw/0823 172540 HRA Approval GOTHIC1: A feasibility trial of glycopyrrolate in comparison to hyoscine hydrobromide and placebo in the treatment of clozapine-induced hypersalivation Yes 09/03/2017 18 24 42 Yes 01/06/2015 26/01/2017 09/08/2016 26/01/2017 13/02/2017 13/02/2017 trial
103581 15/LO/1665 188241 SAFETXT:A randomised controlled of an intervention delivered by mobile phone messaging to reduce sexually transmitted infections (STI) by increasing sexual health precaution behaviours in young people Yes 27/05/2017 85 30 115 No 09/11/2016 01/02/2017 27/04/2016 01/02/2017 27/04/2017 28/04/2017 G - No patients consented Patients meeting the criteria were screened and offered the opportunity to take part however none completed the online enrolment prior to the first recruit target deadline Neither 103582 16/SC/0615 210762 A Phase 4 open-label randomized controlled study COmparing the effectiveness of adalimumab iNTROduction and methotrexate dose escaLation in subjects with Psoriatic Arthritis No 34 No 23/05/2016 29/03/2017 10/02/2017 11/04/2017 02/05/2017 03/05/2017 E - Staff availability issues The Prinicipal investigator has given notice to leave the Trust prior to recruiting any participants, we are therefore arranging a suitable Principal Investigator before we can commence recruitment NHS provider 103583 17/NW/0089 201644 CARMS: A psychological intervention for suicide applied to patients with psychosis: the CARMS trial Yes 21/06/2017 14 27 41 Yes 23/02/2017 11/05/2017 11/05/2017 06/03/2017 25/05/2017 25/05/2017 103584 16/NW/0893 209020 Managing Adolescent first episode Psychosis: a feasibility Study No 42 Within 70 days 13/03/2017 26/04/2017 09/02/2017 10/04/2017 07/06/2017 08/06/2017 F- no patients seen Difficulty in identifying participants who meet the inclusion criteria Neither